CD16 (alpha unit)
Use this icon in our BioRender software along with 1000s of others. Create your next scientific figure in minutes!
SIGN UP FREE[{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337c5/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337c5/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337c4/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337c4/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337c3/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337c3/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337c2/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337c2/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337c1/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337c1/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337c0/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337c0/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337bf/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337bf/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337be/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337be/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337bd/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337bd/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337bc/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337bc/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337bb/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337bb/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337ba/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337ba/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337b9/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337b9/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337b8/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337b8/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337b7/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337b7/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337b6/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337b6/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337b5/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337b5/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337b4/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337b4/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337b3/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337b3/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337b2/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337b2/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337b1/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337b1/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337b0/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337b0/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337af/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337af/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337ae/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337ae/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337ad/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337ad/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337ac/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337ac/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337ab/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337ab/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337aa/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337aa/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337a9/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337a9/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337a8/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337a8/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337a7/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337a7/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337a6/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337a6/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337a5/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337a5/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337a4/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337a4/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337a3/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337a3/cd16-alpha-unit.png"},{"image":"https://icons.biorender.com/w75xh75/5fe1136a76b8e700283337a2/cd16-alpha-unit.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fe1136a76b8e700283337a2/cd16-alpha-unit.png"}]
Keywords
CD16,Fc receptor,Fc region,FcγRIII,FCGR3A,α-chain,alpha chain,α chain,alpha-unit,Ig-like,Ig like,immunoglobin-like,alpha unit,CD16